These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1637301)

  • 21. Recombinant coho salmon insulin-like growth factor I. Expression in Escherichia coli, purification and characterization.
    Moriyama S; Duguay SJ; Conlon JM; Duan C; Dickhoff WW; Plisetskaya EM
    Eur J Biochem; 1993 Nov; 218(1):205-11. PubMed ID: 8243465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential stability of recombinant human insulin-like growth factor II in Escherichia coli and Staphylococcus aureus.
    Hammarberg B; Moks T; Tally M; Elmblad A; Holmgren E; Murby M; Nilsson B; Josephson S; Uhlén M
    J Biotechnol; 1990 Jun; 14(3-4):423-37. PubMed ID: 1366914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human insulin. VIII. Isolation of fusion protein--S-sulfonate, biotechnological precursor of human insulin, from the biomass of transformed Escherichia coli cells.
    Tikhonov RV; Pechenov SE; Belacheu IA; Yakimov SA; Klyushnichenko VE; Boldireva EF; Korobko VG; Tunes H; Thiemann JE; Vilela L; Wulfson AN
    Protein Expr Purif; 2001 Feb; 21(1):176-82. PubMed ID: 11162404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and characterization of the recombinant selenomethionine analogue of insulin-like growth factor-I.
    De Bree FM; Brzozowski AM; Gellerfors P; Karlsson G; Rönnholm H; Breme U; Caccia P; Taylor G; Orsini G
    Protein Expr Purif; 1998 Aug; 13(3):319-25. PubMed ID: 9693056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromatography of recombinant proteins.
    O'Connor JV
    Dev Biol Stand; 1999; 97():39-47. PubMed ID: 10463529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A simple method for the purification of an antimicrobial peptide in recombinant Escherichia coli.
    Hwang SW; Lee JH; Park HB; Pyo SH; So JE; Lee HS; Hong SS; Kim JH
    Mol Biotechnol; 2001 Jul; 18(3):193-8. PubMed ID: 11503514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recovery of extracellular human insulin-like growth factor-I and II as a fusion protein from Escherichia coli culture broth by aqueous two-phase extraction.
    Köhler K; Nilsson B; Veide A
    Bioseparation; 1992-1993; 3(4):241-50. PubMed ID: 1369247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production and characterization of recombinant chicken insulin-like growth factor-II from Escherichia coli.
    Upton Z; Francis GL; Kita K; Wallace JC; Ballard FJ
    J Mol Endocrinol; 1995 Feb; 14(1):79-90. PubMed ID: 7772242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of recombinant human glucose-dependent insulinotropic polypeptide in Escherichia coli by sequence-specific proteolysis of a protein A fusion protein.
    Chow BK; Morrow GW; Ho M; Pederson RA; McIntosh CH; Brown JC; MacGillivray RT
    Peptides; 1990; 11(6):1069-74. PubMed ID: 2087431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The cloning and expression of rat insulin-like growth factor I gene].
    Liang DC; Guo G; Zuo AJ; Zhang JY
    Yi Chuan Xue Bao; 2002 Dec; 29(12):1063-7. PubMed ID: 12693096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficient Soluble Expression and Purification of Recombinant Human Acidic Fibroblast Growth Factor from Escherichia coli via Fusion with a Novel Collagen-like Protein Scl2.
    Rahman IU; Liu W; Wei Z; Fang L; Zheng X; Huang L; Xu Z
    Appl Biochem Biotechnol; 2020 Aug; 191(4):1562-1579. PubMed ID: 32166590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and mutagenesis of an IgG-binding protein based upon protein A of Staphylococcus aureus.
    Popplewell AG; Gore MG; Scawen M; Atkinson T
    Protein Eng; 1991 Dec; 4(8):963-70. PubMed ID: 1817260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glutamic acid gamma-monohydroxamate and hydroxylamine are alternate substrates for Escherichia coli asparagine synthetase B.
    Boehlein SK; Schuster SM; Richards NG
    Biochemistry; 1996 Mar; 35(9):3031-7. PubMed ID: 8608142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inability of a mouse cell line transformed to produce biologically active recombinant human insulin-like growth factor I (IGF-I) to respond to exogenously added IGF-I.
    Cascieri MA; Hayes NS; Kelder B; Kopchick JJ; Chicchi GG; Slater EE; Bayne ML
    Endocrinology; 1988 Apr; 122(4):1314-20. PubMed ID: 2964361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of porcine pancreatic phospholipase A2. Generation of active enzyme by sequence-specific cleavage of a hybrid protein from Escherichia coli.
    de Geus P; van den Bergh CJ; Kuipers O; Verheij HM; Hoekstra WP; de Haas GH
    Nucleic Acids Res; 1987 May; 15(9):3743-59. PubMed ID: 3295782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural changes in insulin-like growth factor (IGF) I mutant proteins affecting binding kinetic rates to IGF binding protein 1 and IGF-I receptor.
    Jansson M; Uhlen M; Nilsson B
    Biochemistry; 1997 Apr; 36(14):4108-17. PubMed ID: 9100004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and characterization of photoreactive insulin-like growth factor 1 derivatives for receptor analysis.
    Fabry M
    Bioconjug Chem; 1999; 10(2):200-5. PubMed ID: 10077468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials.
    Urieto JO; Liu T; Black JH; Cohen KA; Hall PD; Willingham MC; Pennell LK; Hogge DE; Kreitman RJ; Frankel AE
    Protein Expr Purif; 2004 Jan; 33(1):123-33. PubMed ID: 14680969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of succinimide sites in proteins by N-terminal sequence analysis after alkaline hydroxylamine cleavage.
    Kwong MY; Harris RJ
    Protein Sci; 1994 Jan; 3(1):147-9. PubMed ID: 8142891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new protein conjugate that replaces the use of secondary antibodies engineered from the two staphylococcal enzymes protein A and 6-phospho-beta-galactosidase.
    Witt E; Stewart GC; Hengstenberg W
    Protein Eng; 1992 Apr; 5(3):267-71. PubMed ID: 1409548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.